AMPH stock forecast
Our latest prediction for Amphastar Pharmaceuticals, Inc.'s stock price was made on the Jan. 21, 2020 when the stock price was at 19.99$.
In the short term (2weeks), AMPH's stock price should underperform the market by -1.12%. During that period the price should oscillate between -6.38% and +4.73%.
In the medium term (3months), AMPH's stock price should underperform the market by -4.36%. During that period the price should oscillate between -22.21% and +12.95%.Get email alerts
About Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment manufactures and distributes recombinant human insulin and porcine insulin. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.
At the moment the company generates 329M USD in revenues.
On its last earning announcement, the company reported a profit of 1.04$ per share.
The book value per share is 6.93$
Three months stock forecastJan. 21, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|